Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03840096 · ClinicalTrials.gov registry record · NA

Effectiveness of BREG Flex in 12-week Peri-operative Total Knee Arthroplasty

A NA study of Knee Osteoarthritis, sponsored by The Hawkins Foundation.

Completed
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT03840096 is a NA study of Knee Osteoarthritis that has completed, run by The Hawkins Foundation. The registered enrollment target is 200 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (34% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03840096, a NA study of Knee Osteoarthritis, has completed, sponsored by The Hawkins Foundation.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

Patient outcomes following total knee replacement and standard physical therapy will be compared between subjects who use the Breg Flex study device vs those who do not. Subjects will be evaluated for knee range of motion, strength and patient reported outcomes.

Conditions Studied

Interventions

  • DEVICE Breg Flex

Study Locations (2)

South Carolina

  • ATI Physical Therapy - Greenville
  • Steadman Hawkins Clinic of the Carolinas - Greenville Health System - Greenville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-06-01
Est. Completion 2021-06-15
Phase NA

Sponsor

The Hawkins Foundation

11 total trials

What the Registry Record Tells You About NCT03840096

The ClinicalTrials.gov registry entry for NCT03840096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (34% lower). The listed sponsor is The Hawkins Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Breg Flex is the first listed.

NCT03840096 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03840096 about?

NCT03840096 is a clinical study titled "Effectiveness of BREG Flex in 12-week Peri-operative Total Knee Arthroplasty". Patient outcomes following total knee replacement and standard physical therapy will be compared between subjects who use the Breg Flex study device vs those who do not. Subjects will be evaluated for knee range of motion, strength and patient reported outcomes.

What is the current status of trial NCT03840096?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2018-06-01. Estimated completion is 2021-06-15.

What conditions does trial NCT03840096 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT03840096?

The interventions under investigation include: Breg Flex (DEVICE).

Who is sponsoring clinical trial NCT03840096?

This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03840096 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.